CARLSBAD, Calif., Nov. 28, 2018 /PRNewswire/ -- Qualigen, Inc., a privately-owned company that provides novel diagnosticand therapeutic technologies for the treatment of cancer and infectious diseases, announced today the issuance of China Patent Number ZL 2017 30589986.5, which covers the design of Qualigen's novel FastPack 2.0 Sample Port. The patent, which provides
About Qualigen, Inc.Qualigen, Inc. is a medical device company focused on the development, production and commercialization of innovative medical technologies, including its flagship FastPack® point-of-care immunoassay system and novel therapeutic technologies for treatment of cancers and infectious diseases. For more information, visit www.qualigeninc.com.
View original content:http://www.prnewswire.com/news-releases/qualigen-announces-new-patent-issued-for-its-fastpack-2-0-system-in-china-300757214.html
SOURCE Qualigen, Inc.
Subscribe to our Free Newsletters!